Baker Brothers Advisors - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$2,083,000
-12.6%
216,9900.0%0.02%
-5.3%
Q3 2017$2,383,000
+21.3%
216,9900.0%0.02%
+11.8%
Q2 2017$1,964,000
-29.5%
216,9900.0%0.02%
-26.1%
Q1 2017$2,786,000
+36.6%
216,9900.0%0.02%
+15.0%
Q4 2016$2,040,000
-3.4%
216,9900.0%0.02%
+5.3%
Q3 2016$2,111,000
+45.0%
216,9900.0%0.02%
+26.7%
Q2 2016$1,456,000
-24.8%
216,9900.0%0.02%
-25.0%
Q1 2016$1,936,000
-32.7%
216,9900.0%0.02%
-16.7%
Q4 2015$2,875,000
+25.8%
216,9900.0%0.02%
+14.3%
Q3 2015$2,285,000
-61.3%
216,9900.0%0.02%
-59.6%
Q2 2015$5,904,000
-11.1%
216,9900.0%0.05%
-5.5%
Q1 2015$6,642,000
+88.6%
216,990
+130.6%
0.06%
+52.8%
Q4 2014$3,522,000
+7.1%
94,0950.0%0.04%
-12.2%
Q3 2014$3,288,000
-24.9%
94,0950.0%0.04%
-24.1%
Q2 2014$4,380,000
+140.0%
94,095
+59.2%
0.05%
+134.8%
Q1 2014$1,825,000
+29.8%
59,095
-3.6%
0.02%
+15.0%
Q4 2013$1,406,00061,3300.02%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$35,031,00023.03%
Palo Alto Investors LP 5,267,652$81,543,0004.28%
Fairmount Funds Management LLC 702,351$10,872,0003.89%
Birchview Capital, LP 188,000$2,910,0001.68%
Mesirow Financial Investment Management, Inc. 22,303$345,250,0001.09%
EMERALD ADVISERS, LLC 1,822,781$28,217,0000.94%
EMERALD MUTUAL FUND ADVISERS TRUST 1,661,236$25,716,0000.90%
RICE HALL JAMES & ASSOCIATES, LLC 1,552,504$24,033,0000.85%
Altium Capital Management LP 133,951$2,074,0000.77%
Hood River Capital Management LLC 931,754$14,424,0000.48%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders